Thoracic Catheters Market to Reach USD 592 Million by 2034 | Growth Insights According to a newly published market research report by 24LifeSciences, global thoracic catheters market was valued at USD 375 million in 2025 and is projected to grow from USD 400 million in 2026 to reach USD 592 million by 2034, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period. Thoracic catheters, clinically known as chest tubes or intercostal drainage catheters, are indispensable medical devices used to drain air, blood, fluid, or pus from the pleural space. Their core function is to restore negative intrapleural pressure, allowing the lung to re-expand following conditions like pneumothorax, hemothorax, pleural effusion, or post-operative drainage. These procedures are fundamental in thoracic surgery, pulmonology, emergency medicine, and critical care, making thoracic catheters a cornerstone of life-saving interventions worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7653/thoracic-catheters-market

What Is the Future of the Phoropters and Autorefractors Market? Growth Insights According to a newly published market research report by 24LifeSciences, global Phoropters and Autorefractors market is valued at USD 1.8 billion in 2026 and is projected to reach USD 2.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. Phoropters and autorefractors are indispensable diagnostic instruments used in optometric and ophthalmic practices to determine a patient's precise eyeglass prescription. A phoropter is a manual device containing a range of lenses that an eye care professional uses during a subjective refraction test, allowing for fine-tuned adjustments based on patient feedback. In contrast, an autorefractor is an automated computerized instrument that provides an objective, rapid measurement of a person's refractive error, serving as a critical starting point for the prescription process. These devices are fundamental for diagnosing and managing common vision conditions such as myopia, hyperopia, astigmatism, and presbyopia, forming the cornerstone of comprehensive eye examinations worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9993/phoropters-and-autorefractors-market

What Is the Future of the Dental Electrosurgical Generators Market? Growth Insights According to a newly published market research report by 24LifeSciences, global dental surgery electrosurgical generators market was valued at USD 285 million in 2024 and is projected to reach USD 425 million by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period. Dental surgery electrosurgical generators are advanced medical devices that produce high-frequency electrical currents for cutting, coagulating, desiccating, and fulgurating tissues during dental procedures. These systems are indispensable in modern dentistry, enabling precise soft tissue management with minimized bleeding and enhanced surgical visibility. Available in monopolar and bipolar configurations, they are essential tools for procedures ranging from gingivectomies to implantology, supporting both routine and complex oral surgeries. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10136/dental-surgery-electrosurgical-generators-market

FibroTouch Devices Market Size to Reach USD 220 Million by 2032 | Growth Insights Global FibroTouch Devices market is undergoing steady expansion as healthcare systems increasingly prioritize non-invasive diagnostics for liver disease management. Valued at USD 120 million in 2024, the market is projected to grow from USD 132 million in 2025 to USD 220 million by 2032, registering a CAGR of 7.8% during the forecast period. This growth reflects a structural shift away from invasive liver biopsies toward faster, safer, and more patient-friendly elastography-based solutions that deliver real-time clinical insights. The FibroTouch Devices market is gaining prominence across hospitals, diagnostic centers, and specialty clinics as chronic liver conditions such as NAFLD, viral hepatitis, and alcoholic liver disease continue to rise globally. Increasing disease awareness, early screening initiatives, and technological refinements are positioning FibroTouch as a core diagnostic modality in modern hepatology workflows. Access the market report https://www.24lifesciences.com/fibrotouch-devices-market-9969

Tardive Dyskinesia Treatment Market Size to Reach USD 1.3 Billion by 2032 | Growth Insights Global Tardive Dyskinesia Treatment market is undergoing a notable transformation as healthcare systems prioritize early diagnosis, neurological specialization, and precision pharmacotherapy. Valued at USD 643.5 million in 2024, the market is projected to grow from USD 720.6 million in 2025 to USD 1.3 billion by 2032, expanding at a CAGR of 9.2% during the forecast period. Rising awareness of movement disorders, increased use of long-term antipsychotic therapies, and the growing adoption of FDA-approved VMAT2 inhibitors are central to this sustained growth trajectory. Access the market report https://www.24lifesciences.com/tardive-dyskinesia-treatment-market-10341